Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer?
Montemurro
Filippo
F
Institute for Cancer Research and Treatment (IRCC), Candiolo (TO), Italy. filippo.montemurro@ircc.it
Aglietta
Massimo
M